Skip to content
Clinical Trials – home

Pyelonephritis acute Diagnostics

5 / 7 trials open to patients15 countries

In short

When kidney pain strikes with fever and burning during urination, quick and accurate testing becomes essential to protect these vital organs from lasting harm.

Key points

  • A simple urine test combined with your symptoms can usually diagnose a kidney infection without expensive imaging studies in uncomplicated cases
  • The classic finding of pain when a doctor taps your back over the kidney area appears in nearly all kidney infections and helps distinguish them from bladder infections
  • E. coli causes about 90% of kidney infections, but determining which antibiotics work against your specific bacteria requires a urine culture, not just a basic urinalysis
  • Young women aged 15-29 are most commonly affected, but older adults may present with confusion rather than typical symptoms, making diagnosis more challenging
  • Your urine sample must reach the lab within 30 minutes or be refrigerated—bacteria multiplying in a delayed sample can lead to inaccurate results
  • If you don't improve within 48-72 hours of starting antibiotics, imaging becomes necessary to look for complications like abscesses or kidney stones
  • Blood cultures are positive in only 20-30% of kidney infection cases and aren't routinely needed unless you're severely ill or hospitalized
  • Antibiotic resistance is rising dramatically—E. coli resistance now exceeds 35% for some common medications, making culture results critical for treatment success

Introduction: Who Needs Testing and When

If you experience sudden pain in your lower back or side, especially combined with fever or changes in urination, you should seek medical attention promptly. Acute pyelonephritis, which is the medical term for a kidney infection, requires timely diagnosis to prevent complications that could permanently damage your kidneys.

Young women between 15 and 29 years old are most commonly affected by this condition, though anyone can develop it at any age. If you have symptoms that suggest a urinary tract infection—such as frequent or painful urination—and then develop fever, back pain, nausea, or vomiting, this pattern suggests the infection may have moved from your bladder up to your kidneys.

People with certain health conditions should be especially alert. If you have diabetes, a weakened immune system, kidney stones, or any structural problems in your urinary tract, you face higher risks for both developing the infection and experiencing more serious complications. Pregnant women also need immediate medical care if they suspect a kidney infection, as they are at significantly elevated risk of severe outcomes.

The decision to seek testing should not be delayed. Unlike simple bladder infections that might cause mild discomfort, kidney infections tend to make people feel much sicker, much faster. The typical pattern includes high fever—often above 100.4°F (38°C)—combined with pain in the flank area, which is the region just below your rib cage and above your waist on either side of your back.

Diagnostic Methods for Identifying Acute Pyelonephritis

Medical History and Physical Examination

Your doctor will begin by asking detailed questions about your symptoms. The combination of symptoms matters greatly in reaching the correct diagnosis. Most patients describe fever, chills, and pain in the back or side. Many also report symptoms related to the lower urinary tract, such as burning during urination, needing to urinate frequently, or feeling an urgent need to go even when little urine comes out.

During the physical examination, your healthcare provider will check for costovertebral angle tenderness, which is pain felt when the doctor gently taps the area of your back where your kidneys are located. This specific finding is nearly universal in kidney infections and helps distinguish them from other conditions. The doctor will also examine your abdomen for tenderness and may check your vital signs, including blood pressure and heart rate, to assess the severity of the infection.

It is important to note that symptoms can vary considerably depending on age. In babies and young children under two years old, high fever may be the only noticeable sign, sometimes accompanied by poor feeding or vomiting. In older adults, the typical symptoms might be absent entirely, and instead they may present with confusion, jumbled speech, or changes in mental status that could easily be mistaken for other conditions.

Urinalysis: The Essential First Test

The most important initial diagnostic test is urinalysis, which is an examination of your urine sample. This test looks for several key indicators of infection. The presence of white blood cells in the urine, a condition called pyuria, suggests that your body is fighting an infection. Red blood cells may also appear, causing the urine to look bloody or cloudy, a finding known as hematuria. The urine may also have an unusual or unpleasant smell.

The urinalysis typically includes two specific tests that work together to detect infection. The leukocyte esterase test detects an enzyme released by white blood cells, while the nitrite test identifies substances produced when bacteria break down urine components. When either of these tests comes back positive, the combination has a sensitivity of 75 to 84 percent and a specificity of 82 to 98 percent for urinary tract infection.

To ensure accurate results, the urine sample must be collected properly. For most patients, this means providing a clean-catch, midstream sample. The sample should reach the laboratory within 30 minutes of collection, or it should be refrigerated at 4°C and tested within 18 hours. This timing is critical because bacteria can multiply in the sample if it sits at room temperature, potentially leading to misleading results.

Urine Culture and Sensitivity Testing

A urine culture should be obtained from every patient before starting antibiotic treatment. This test is more detailed than a simple urinalysis because it actually grows the bacteria from your urine sample in a laboratory, allowing technicians to identify exactly which type of bacteria is causing the infection. Urine cultures are positive in about 90 percent of patients with acute pyelonephritis.

The culture typically shows bacterial counts exceeding 100,000 colony-forming units per milliliter, which indicates a true infection rather than contamination. In most cases—approximately 90 percent—the culprit is a bacterium called Escherichia coli, commonly known as E. coli. Other bacteria that can cause kidney infections include Proteus mirabilis, Enterobacter, Staphylococcus, and Klebsiella species.

Equally important is the antimicrobial susceptibility testing that accompanies the culture. This testing determines which antibiotics will be effective against the specific bacteria causing your infection. Because antibiotic resistance has become increasingly common—with E. coli resistance to common antibiotics like trimethoprim/sulfamethoxazole exceeding 35 percent in some areas—knowing which medications will actually work is essential for successful treatment.

Blood Tests and Cultures

For patients being evaluated in the emergency department or those being admitted to the hospital, blood tests provide additional information about the severity of the infection. A full blood count can show elevated white blood cells, a sign that your body is mounting an immune response. Tests measuring erythrocyte sedimentation rate and C-reactive protein indicate the level of inflammation in your body.

Your doctor may also order tests to check kidney function, including measurements of urea, electrolytes, and creatinine in your blood. These tests help identify whether the infection has begun to affect how well your kidneys are working. Blood cultures, which check for bacteria in the bloodstream, are positive in about 20 to 30 percent of patients with kidney infections. However, for uncomplicated cases in otherwise healthy people, blood cultures are not routinely necessary.

Imaging Studies: When Are They Needed?

Imaging tests are not required for straightforward cases of acute pyelonephritis in otherwise healthy patients. Most people respond well to appropriate antibiotic treatment within 48 to 72 hours, and imaging studies add little value in these uncomplicated situations.

However, imaging becomes important in several specific circumstances. If you do not improve after two to three days of appropriate antibiotic therapy, imaging can help identify complications such as abscesses or obstructions. Imaging is also indicated if you appear severely ill or septic, if kidney stones or urinary obstruction are suspected, or if you have recurrent kidney infections that might suggest an underlying structural problem.

Contrast-enhanced computed tomography, commonly called a CT scan with contrast, is generally the preferred imaging method when complications are suspected. This test provides detailed pictures of your kidneys and can identify problems such as kidney abscesses, gas formation in the kidney tissue (a serious complication called emphysematous pyelonephritis), or obstructions caused by stones. The contrast dye used in this test helps highlight areas of infection or inflammation.

Renal ultrasound is another imaging option, particularly useful for pregnant women and children in whom radiation exposure should be minimized. Ultrasound can detect kidney stones, abscesses, and structural abnormalities, though it is generally not as detailed as CT scanning. Magnetic resonance imaging (MRI) is sometimes used as an alternative to CT, especially when contrast dye cannot be given due to allergies or kidney function concerns.

Diagnostic Criteria for Clinical Trial Enrollment

When patients with acute pyelonephritis are considered for enrollment in clinical trials testing new treatments, researchers use standardized diagnostic criteria to ensure that all participants truly have the condition being studied. These criteria typically require both clinical evidence and laboratory confirmation of the infection.

The clinical criteria usually include the presence of flank pain or costovertebral angle tenderness, which are physical findings strongly associated with kidney infection. Fever is another key criterion, typically defined as a body temperature at or above 38°C (100.4°F). Many trials also require documentation of lower urinary tract symptoms such as painful urination, urgency, or frequency, though these symptoms may be absent in some patients with confirmed kidney infections.

Laboratory confirmation for trial enrollment generally requires evidence of infection on urinalysis, most commonly the presence of white blood cells (pyuria) or bacteria (bacteriuria) in the urine. A positive urine culture demonstrating bacterial growth—typically more than 100,000 colony-forming units per milliliter—is often required before a patient can be enrolled. The culture also identifies the specific bacteria causing the infection, which helps ensure that the treatment being tested is appropriate for the pathogens involved.

Clinical trials often distinguish between uncomplicated and complicated pyelonephritis, as these groups may respond differently to treatment. Uncomplicated cases typically occur in otherwise healthy individuals with normal urinary tract anatomy. Complicated cases include those occurring in people with diabetes, immunosuppression, pregnancy, structural abnormalities of the urinary tract, kidney stones, urinary catheters, or recent urinary procedures. Many trials focus exclusively on one category or the other to ensure that results can be interpreted clearly.

Some trials require imaging studies as part of their enrollment criteria, particularly when studying treatments for complicated infections or when trying to identify specific complications such as abscesses. Blood cultures may also be required in certain trials, especially those focused on severe infections or hospitalized patients. Baseline kidney function tests, including measurements of creatinine and estimated glomerular filtration rate, help researchers understand how the infection and treatment affect kidney function over time.

Prognosis and Survival Rate

Prognosis

Most people with acute pyelonephritis respond well to appropriate antibiotic treatment within 48 to 72 hours and recover completely without lasting kidney damage. The prognosis for uncomplicated cases in otherwise healthy individuals is generally excellent, with symptoms typically beginning to improve within a few days of starting treatment. However, the infection must be treated promptly and completely to prevent complications.

Several factors can affect the prognosis. People with underlying health conditions such as diabetes, weakened immune systems, or structural abnormalities of the urinary tract face higher risks of complications and may require more aggressive treatment. Pregnant women with kidney infections are at significantly elevated risk of severe complications and require hospital admission. The development of complications such as kidney abscesses, emphysematous pyelonephritis (where bacteria destroy kidney tissue and create gas), or renal papillary necrosis (damage to kidney structures) worsens the prognosis and may require surgical intervention in addition to antibiotics.

Even a single episode of acute pyelonephritis can potentially cause permanent kidney scarring, which may lead to high blood pressure or reduced kidney function in the future. This is why prompt treatment is so critical, particularly in young children under age two, where the risk of permanent damage is highest. Repeated kidney infections increase the cumulative risk of kidney damage and in rare cases can ultimately lead to chronic kidney disease requiring dialysis or transplantation.

Patients who develop sepsis—where the infection spreads to the bloodstream causing a body-wide response—face a more serious situation requiring intensive hospital care. Without treatment, sepsis can progress to septic shock and multi-organ failure, which can be life-threatening. However, with appropriate and timely antibiotic therapy and supportive care, most patients with sepsis from kidney infections recover.

Survival rate

Acute pyelonephritis, when diagnosed and treated appropriately, rarely leads to death in otherwise healthy individuals. The mortality rate for uncomplicated kidney infections in healthy people is extremely low. However, the condition becomes more serious in vulnerable populations. Elderly patients, those with significant underlying diseases, pregnant women, and immunocompromised individuals face higher risks of severe complications that can be life-threatening if not promptly and aggressively treated.

In very rare cases—particularly when diagnosis is delayed, treatment is inadequate, or serious complications develop—untreated pyelonephritis can cause death. The development of septic shock from kidney infection carries significant mortality risk, though exact percentages vary depending on the patient population, the severity of illness at presentation, and the timeliness of appropriate treatment. With modern medical care including effective antibiotics, supportive care, and surgical intervention when needed, the vast majority of patients survive and recover from kidney infections.

Did you know?

  1. Approximately 70% of healthcare decisions depend on diagnostic test results, yet only 3-5% of healthcare budgets typically go toward diagnostic services worldwide.
  2. Studies using specialized markers have shown that many women who initially present with symptoms suggesting only a bladder infection actually have kidney involvement that becomes apparent only when short-course treatment fails.
  3. The bacteria causing kidney infections reach the kidneys by traveling upward through the urinary tract in most cases, but in rare instances they can arrive through the bloodstream from infections in completely different parts of the body.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Pyelonephritis acute

Recruiting trials first

See all 7 trials →
Quick filters

7 clinical trials in this condition

Countries:CzechiaCzechia
  • Participants:0–17 years
  • Substances:Meropenem
  • Sponsor:Menarini Ricerche S.p.A.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ciprofloxacin
  • Sponsor:UZ Brussel
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sulfamethoxazole
  • Sponsor:Assistance Publique Hopitaux De Paris

Pyelonephritis acute

Not yet recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:0–17 years
  • Substances:Cefepime
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Amikacin Sulfate
  • Sponsor:Assistance Publique Hopitaux De Paris
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Meropenem
  • Sponsor:Rempex Pharmaceuticals Inc.
See all 7 trials →filters applied: condition = Pyelonephritis acute

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).